Cross-Family Mechanistic Analysis of Plant Alkaloids Against Neglected Arboviruses and Related RNA Viruses.

Cross-Family Mechanistic Analysis of Plant Alkaloids Against Neglected Arboviruses and Related RNA Viruses.

Publication date: Aug 06, 2026

Neglected arboviruses dengue (DENV), Zika (ZIKV), yellow fever (YFV), Japanese encephalitis (JEV), and chikungunya collectively affect hundreds of millions of people annually, yet no specific antiviral drug has been approved for any of them. Alkaloids, nitrogen-containing specialized metabolites produced by diverse plant families, have emerged as a promising source of broad-spectrum antiviral scaffolds. This review compiles and critically analyzes over 100 alkaloid-virus pairs across several RNA virus families, providing a comparative mechanistic analysis. Lycorine, narciclasine, emetine, and berbamine, among others, exhibit potent activity against phylogenetically distant viruses, with the most potent activities reported against flaviviruses (narciclasine: EC 0. 02 uM against DENV, ZIKV, YFV, and JEV; pancratistatine: 0. 0063 uM against ZIKV). Structure-activity analysis of multiple alkaloid classes identifies key pharmacophoric features, including the phenanthridine nucleus (lycorine derivatives) and the bis-benzylisoquinoline scaffold (tetrandrine, berbamine), as determinants of antiviral potency, selectivity, and broad-spectrum activity. Genetic resistance data in West Nile virus challenge the widely accepted model of lycorine as a direct nucleoside inhibitor, instead pointing toward the involvement of the membrane-associated NS4A-2K-NS4B replication complex, though direct validation remains limited for other flaviviruses. Converging structural, biochemical, and transcriptomic evidence suggests that ribosome-mediated translational stress may represent an additional host-directed antiviral mechanism for isoquinoline-type alkaloids, though the causal chain from ribosome binding to activation of the integrated stress response and to antiviral effect has not been established. The present analysis highlights that in vivo validation remains limited to a few alkaloid-virus pairs. Unbiased target deconvolution and formal testing of the ribosome/integrated stress response hypothesis stand out as essential research priorities.

Open Access PDF

Concepts Keywords
Annually Alkaloids
Arboviruses Alkaloids
Benzylisoquinoline Animals
Japanese Antiviral Agents
Unbiased Antiviral Agents
Arboviruses
broad-spectrum antivirals
flavivirus
Humans
integrated stress response
mechanism of action
neglected tropical diseases
Plants
ribosome
RNA Viruses
Structure-Activity Relationship
structure-activity relationships
Virus Replication

Semantics

Type Source Name
disease MESH dengue
disease MESH yellow fever
disease MESH Japanese encephalitis
drug DRUGBANK Nitrogen
drug DRUGBANK Tetrandrine
pathway KEGG Ribosome
drug DRUGBANK Isoquinoline
disease MESH neglected tropical diseases
disease MESH Viral Diseases
disease MESH infections
disease MESH fever
disease MESH headache
disease MESH pain
disease MESH joint pain
disease MESH nausea
disease MESH vomiting
disease MESH skin rash
disease MESH dengue hemorrhagic fever
disease MESH Reinfection
disease MESH abdominal pain
disease MESH bleeding
disease MESH conjunctivitis
disease MESH syndrome
disease MESH microcephaly
disease MESH viral encephalitis
disease MESH NS3
pathway REACTOME Translation
disease MESH hepatitis
drug DRUGBANK Indole
drug DRUGBANK Morphine
drug DRUGBANK Quinine
drug DRUGBANK Vincristine
drug DRUGBANK Galantamine
drug DRUGBANK Celgosivir
drug DRUGBANK Castanospermine
pathway KEGG Endocytosis
drug DRUGBANK Berberine
disease MESH Cep
drug DRUGBANK Piperine
pathway REACTOME Budding
drug DRUGBANK Coenzyme M
drug DRUGBANK Atropine
drug DRUGBANK Ipecac
disease MESH NS5
disease MESH influenza
disease MESH included
drug DRUGBANK Tropicamide
disease MESH infectious diseases
disease MESH severe acute respiratory syndrome
disease MESH Middle East respiratory syndrome
disease MESH parainfluenza
pathway KEGG Viral replication
disease MESH strains
drug DRUGBANK Angiotensin II
disease MESH PTC
drug DRUGBANK Omacetaxine mepesuccinate
disease MESH Hed

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *